Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 88


Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

Weinberg A, Bosch R, Bennett K, Tovar-Salazar A, Benson CA, Collier AC, Zolopa A, Gulick RM, Wohl D, Polsky B, Erice A, Jacobson MA.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):25-32. doi: 10.1097/QAI.0000000000000095.


[Prevalence of HIV infection among healthy workers].

Erice A, Chiaraviglio A.

Med Clin (Barc). 2011 Apr 16;136(10):458-9. doi: 10.1016/j.medcli.2009.07.035. Epub 2009 Oct 12. Spanish. No abstract available.


Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C.

Bartolomé J, Rodríguez-Iñigo E, Erice A, Vidal S, Castillo I, Carreño V.

J Med Virol. 2007 Dec;79(12):1818-20.


The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB; AIDS Clinical Trials Group 328 Study Team.

Arch Intern Med. 2007 Mar 26;167(6):597-605.


Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.

Mallolas J, Arnedo M, Pumarola T, Erice A, Blanco JL, Martínez E, Gatell JM.

AIDS. 2006 Jan 9;20(2):285-7.


Occam can be wrong: a young man with lumbar pain and acute weakness of the legs.

Neira MI, Sánchez J, Moreno I, Chiaraviglio A, Rayo A, Gutiérrez J, Erice A.

Lancet. 2006 Feb 11;367(9509):540. No abstract available.


Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.

Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B; AIDS Clinical Trials Group 360 Team.

J Infect Dis. 2006 Feb 15;193(4):488-93. Epub 2006 Jan 3.


Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome.

de Górgolas M, Erice A, Gil A, Gutiérrez J, Rivas P, Hernando C, Rodríguez MC.

Scand J Infect Dis. 2005;37(6-7):526-8.


Altered replicative capacity of recombinant HIV type 1 containing mutations at codons 26 and 29 of the viral protease.

Melón S, Gil-Roda C, de Oña M, Erice A.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1183-8.


HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.

Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA; AIDS Clinical Trials Group Protocol 388.

Clin Infect Dis. 2004 Aug 15;39(4):552-8. Epub 2004 Jul 30.


A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.

Fischl MA, Ribaudo HJ, Collier AC, Erice A, Giuliano M, Dehlinger M, Eron JJ Jr, Saag MS, Hammer SM, Vella S, Morse GD, Feinberg JE, Demeter LM, Eshleman SH; Adult AIDS Clinical Trials Group 388 Study Team.

J Infect Dis. 2003 Sep 1;188(5):625-34. Epub 2003 Aug 15. Erratum in: J Infect Dis. 2003 Oct 1;188(7):1083.


Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

Erice A, Tierney C, Hirsch M, Caliendo AM, Weinberg A, Kendall MA, Polsky B; AIDS Clinical Trials Group Protocol 360 Study Team.

Clin Infect Dis. 2003 Aug 15;37(4):567-78. Epub 2003 Jul 29.


Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors.

Henry K, Erice A, Balfour HH Jr, Schmeling M, Berthiaume J, Wallace K.

AIDS. 2002 Dec 6;16(18):2485-7. No abstract available.


Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2.

Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM.

AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):661-5.


Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

Demeter LM, Bosch RJ, Coombs RW, Fiscus S, Bremer J, Johnson VA, Erice A, Jackson JB, Spector SA, Squires KM, Fischl MA, Hughes MD, Hammer SM.

J Clin Microbiol. 2002 Jun;40(6):2089-94.


HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.

Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC; Studies of Ocular Complications of AIDS Research Group.

AIDS. 2002 Apr 12;16(6):877-87.


[GESIDA Consensus document on the use of resistance studies in clinical practice].

Gatell JM, Blanco JL, Alcamí J, Antela A, Arrizabalaga J, Casado JL, Clotet B, Delgado R, Erice A, Guerra L, Guerrero A, Iribarren JA, Leal M, López JC, Menéndez-Arias L, Miró JM, Moreno S, Pérez JL, Pumarola T, Rubio R, Ruiz L, Santamaría JM, Soriano V, Telenti A, Viciana P.

Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):53-60. Review. Spanish. No abstract available.


[Comparative analysis of methods for detecting resistance].

Erice A, Pérez JL, Pumarola T.

Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):14-21. Spanish. No abstract available.


Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals.

Erice A, Li W, Balfour HH Jr, Boies LR Jr, Melroe H, Henry K.

AIDS. 2001 May 4;15(7):831-6.


Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R, Crumpacker C, Lurain NS, Erice A; CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group.

J Clin Microbiol. 2001 Apr;39(4):1334-8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk